US Patent 9415109 Stable non-aggregating nucleic acid lipid particle formulations
Patent 9415109 was granted and assigned to Alnylam Pharmaceuticals on August, 2016 by the United States Patent and Trademark Office.
Is a
Current Assignee
Date Filed
July 3, 2013
0
Date of Patent
August 16, 2016
0
Patent Applicant
Patent Application Number
14412957
0
Patent Inventor Names
Akin Akinc
0
Varun Kumar
0
Patent Jurisdiction
Patent Number
Patent Primary Examiner
Find more entities like US Patent 9415109 Stable non-aggregating nucleic acid lipid particle formulations
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
